Oncoinvent ASA
ONCIN
Rank in Stocks
#27361
Oncoinvent ASA, a clinical-stage firm based in Oslo, Norway, is dedicated to... Oncoinvent ASA, a clinical-stage firm based in Oslo, Norway, is dedicated to developing innovative radiopharmaceutical treatments for various cancers. Its primary therapeutic agent is Radspherin, an alpha-emitting radiotherapeutic, which is currently undergoing investigation in two Phase 1/2a and one randomized Phase 2 clinical trials. This promising candidate is designed to target and treat malignancies that have metastasized to body cavities, specifically including the peritoneum.
Share Price
$7.13
Last synced: 2026-10-16
Market Cap
$31.92M
Change (1 day)
0.00%
Change (1 year)
6,364.10%
Country
NO
Trade Oncoinvent ASA (ONCIN)
Category
Healthcare
Market Capitalization of Oncoinvent ASA(ONCIN)
Market Cap: $31.92M
As of October 2026 Oncoinvent ASA has a market cap of $31.92M. This makes Oncoinvent ASA the world's 27361st most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Oncoinvent ASA from 2017 to 2026
ONCIN compared with Top 5 Most Popular stocks
